A leader in the development of checkpoint inhibitors targeting the innate immune system.
Innate Pharma S.A. is a clinical-stage biotechnology company in the field of immuno-oncology. The Company is focusing on discovering and developing first-in-class therapeutic antibodies designed to harness the innate immune system for treatment of serious unmet medical needs in cancer.
Company's founders, and some of the employees, had significant roles in scientific breakthroughs in the biology of natural killer cells, or NK cells, that made it possible to identify receptors that regulate the activity of innate immunity cells. The Company has built on this expertise to pioneer the discovery and development of checkpoint inhibitors to activate the innate immune system for treatment of cancer.
The Company's research platform also creates opportunities for developing therapies for inflammatory diseases.